Tumor-Responsive Delivery of 5-Fluorouracil from a Redox-Triggered Supramolecular Gelator
Bioconjugate Chemistry · 19.08.2026 · 37 (8) · 1571-1581
DOI: 10.1021/acs.bioconjchem.6c00108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 10.08.2026. Verfasst von Marko Mihajlovic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Pharmaceutical Sciences, University of Trieste, V. Giorgieri 1, Trieste34127, Italy. Hauptthemen laut MEDLINE: Fluorouracil, Hydrogels, Antimetabolites, Antineoplastic, Drug Delivery Systems. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research through the PRIN program, Slovenian Research and Innovation Agency (ARIS).
Abstract (Originalsprache)
5-Fluorouracil (5-FU) is a chemotherapeutic drug that is widely used to treat gastrointestinal cancers (e.g., hepatocellular carcinoma). Unfortunately, its systemic toxicity limits its clinical utility; therefore, new means for its targeted delivery at the pathological site are highly sought after to enhance therapeutic efficacy. In this work, we describe a 5-FU covalent conjugate with the self-assembling, heterochiral tripeptide DLeu-Phe-Phe (lFF) via a redox-sensitive linker (5-FU-SS-lFF). The conjugate yields supramolecular hydrogels with rheological properties similar to those of lFF hydrogels and enables 5-FU release under reducing conditions, such as those present in the tumor microenvironment. We demonstrate the selectivity of the drug release under such conditions over a period of 24 h, with consequent significant cytotoxicity on cancer cells, as demonstrated on hepatocellular carcinoma spheroids. Overall, this study opens new opportunities for peptide-based supramolecular hydrogels as versatile and smart vehicles for the selective release of anticancer drugs under tumor-like reducing conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Pharmaceutical Sciences, University of Trieste, V. Giorgieri 1, Trieste34127, Italy.
- Fondazione Italiana Fegato ONLUS - Italian Liver Foundation NPO , Metabolic Liver Disease Unit, SS14 Km 163.5 Area Science Park Basovizza, Trieste34149, Italy.
- Materials Synthesis Department, Jožef Stefan Institute, Ljubljana1000, Slovenia.
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, Ljubljana1000, Slovenia.
ORCID-Profile: Slavko Kralj, Silvia Marchesan
Förderung
- Italian Ministry of University and Research through the PRIN program
- Slovenian Research and Innovation Agency (ARIS)
Zitieren
APA
Mihajlovic, M., Mihajlovic, M., Alletto, P., Kralj, S., Rosso, N., & Marchesan, S. (2026). Tumor-Responsive Delivery of 5-Fluorouracil from a Redox-Triggered Supramolecular Gelator. Bioconjugate Chemistry, 37(8), 1571-1581. https://doi.org/10.1021/acs.bioconjchem.6c00108
Vancouver
Mihajlovic M, Mihajlovic M, Alletto P, Kralj S, Rosso N, Marchesan S. Tumor-Responsive Delivery of 5-Fluorouracil from a Redox-Triggered Supramolecular Gelator. Bioconjugate Chemistry. 2026;37(8):1571-1581. doi:10.1021/acs.bioconjchem.6c00108
BibTeX
@article{Mihajlovic2026,
author = {Mihajlovic, Marko and Mihajlovic, Milos and Alletto, Paola and Kralj, Slavko and Rosso, Natalia and Marchesan, Silvia},
title = {Tumor-Responsive Delivery of 5-Fluorouracil from a Redox-Triggered Supramolecular Gelator},
journal = {Bioconjugate Chemistry},
year = {2026},
volume = {37},
number = {8},
pages = {1571--1581},
doi = {10.1021/acs.bioconjchem.6c00108}
}
EUVIMED